(Q37156698)

18 August 2017

1 reference

title

Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains (English)

1 reference

methicillin-resistant Staphylococcus aureus

18 August 2017

main subject

0 references

antibiotic resistance

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

1

George Sakoulas

1 reference

18 August 2017

Robert C Moellering

2

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

Clinical Infectious Diseases

18 August 2017

published in

1 reference

18 August 2017

volume

46 Suppl 5

1 reference

18 August 2017

page(s)

S360-7

1 reference

The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database

18 August 2017

cites work

1 reference

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

21 January 2018

1 reference

High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections

21 January 2018

1 reference

Methicillin-resistant Staphylococcus aureus in community-acquired skin infections

21 January 2018

1 reference

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

21 January 2018

1 reference

Linezolid resistance in a clinical isolate of Staphylococcus aureus

21 January 2018

1 reference

Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.

21 January 2018

1 reference

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

21 January 2018

1 reference

Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure.

21 January 2018

1 reference

High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm

21 January 2018

1 reference

Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.

21 January 2018

1 reference

Vancomycin resistance in gram-positive cocci

21 January 2018

1 reference

Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus

21 January 2018

1 reference

Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin

21 January 2018

1 reference

Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains

21 January 2018

1 reference

Decreasing in vitro susceptibility of clinical Staphylococcus aureus isolates to vancomycin at the New York Hospital: quantitative testing redux

21 January 2018

1 reference

Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period

21 January 2018

1 reference

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia.

21 January 2018

1 reference

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

21 January 2018

1 reference

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods

21 January 2018

1 reference

Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus

21 January 2018

1 reference

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility

21 January 2018

1 reference

Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study

21 January 2018

1 reference

Linezolid eradicates MRSA better than vancomycin from surgical-site infections

21 January 2018

1 reference

Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections

21 January 2018

1 reference

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

21 January 2018

1 reference

The pharmacokinetic and pharmacodynamic properties of vancomycin

21 January 2018

1 reference

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

21 January 2018

1 reference

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices

21 January 2018

1 reference

Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus

21 January 2018

1 reference

Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia

21 January 2018

1 reference

Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus

21 January 2018

1 reference

Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin

21 January 2018

1 reference

Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.

21 January 2018

1 reference

Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.

21 January 2018

1 reference

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

21 January 2018

1 reference

Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.

21 January 2018

1 reference

Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis

21 January 2018

1 reference

Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid

21 January 2018

1 reference

Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function

21 January 2018

1 reference

Epidemiological Profile of Linezolid‐Resistant Coagulase‐Negative Staphylococci

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/533592

1 reference

18 August 2017

1 reference